The role of RhoA/Rho kinase pathway in endothelial dysfunction
Open Access
- 1 October 2010
- journal article
- Published by SynthesisHub Advance Scientific Research in Journal of Cardiovascular Disease Research
- Vol. 1 (4) , 165-170
Abstract
Endothelial dysfunction is a key event in the development of vascular disease, and it precedes clinically obvious vascular pathology. Abnormal activation of the RhoA/Rho kinase (ROCK) pathway has been found to elevate vascular tone through unbalancing the production of vasodilating and vasoconstricting substances. Inhibition of the RhoA/ROCK pathway can prevent endothelial dysfunction in a variety of pathological conditions. This review, based on recent molecular, cellular, and animal studies, focuses on the current understanding of the ROCK pathway and its roles in endothelial dysfunction.Keywords
This publication has 76 references indexed in Scilit:
- Rho kinase modulates postnatal adaptation of the pulmonary circulation through separate effects on pulmonary artery endothelial and smooth muscle cellsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2010
- Coordinated RhoA signaling at the leading edge and uropod is required for T cell transendothelial migrationJournal of Cell Biology, 2010
- RhoA/Rho-kinase and vascular diseases: what is the link?Cellular and Molecular Life Sciences, 2010
- Rho Kinase-2 Activation in Human Endothelial Cells Drives Lysophosphatidic Acid-mediated Expression of Cell Adhesion Molecules via NF-κB p65Journal of Biological Chemistry, 2010
- Peroxynitrite Mediates Diabetes-Induced Endothelial Dysfunction: Possible Role of Rho Kinase ActivationExperimental Diabetes Research, 2010
- ROCK Isoform Regulation of Myosin Phosphatase and Contractility in Vascular Smooth Muscle CellsCirculation Research, 2009
- Protein Kinase C-related Kinase and ROCK Are Required for Thrombin-induced Endothelial Cell Permeability Downstream from Gα12/13 and Gα11/qJournal of Biological Chemistry, 2008
- Diabetes-induced Coronary Vascular Dysfunction Involves Increased Arginase ActivityCirculation Research, 2008
- Rho Kinase (ROCK) InhibitorsJournal of Cardiovascular Pharmacology, 2007
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000